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The recent cases of Ebola contagion in
health care workers make evident the lack
of a complete understanding of the infec-
tion process. There are evidences against
respiratory system involvement along the
complete transmission cycle, from an
infected individual to an uninfected one by
the airborne/droplet transmission route.
Main stream knowledge have been the
basis for actions and opinions by agen-
cies such as the CDC, however, accelerated
response may have overlooked gray areas
and missed possible risk scenarios. Among
the most challenging ones, and which could
gain relevance as contact precautions are
set is the accidental aerosol/droplet trans-
mission.
Data supporting this claim sustains
on experimental transmission with ani-
mal models, in addition to pathology and
environmental microbiology findings.
Explanatory analysis accounts mostly
to the susceptibility of exposed respira-
tory and mucous membranes to a source
of low dose aerosolized Ebola virus to
infect by inhalation or autoinoculation via
water or fomites in non-human primates
even when direct contact to the source is
prevented (1, 2).
Even more, Ebola major symptoms,
exception made for respiratory localized
lesions, are quite similar no matter peri-
toneal or aerosol respiratory experimental
inoculation in non-human primates (3).
In humans, suspicion of aerosol transmis-
sion is reinforced because of lung-infected
macrophages in post-mortem fixed tis-
sue (4).
A fact, connecting both susceptibility
and indirect transmission are that the
Zaire Ebola virus decay rate in a dynamic
aerosol would have allowed transmission.
As an example, starting with almost 1000
infectious Zaire Ebola virus, after 90 min,
enough viruses remain infective to cause
disease. Moreover, if adsorbed dry on glass
or plastic at low temperature, number of
infective particles that would remain infec-
tive could be as high as up to 1× 103 times
the reported minimal infectious dose for
days (5).
Speculatively, air suspension or un-
apparent surface deposit could plausibly
explain epidemiologic research in which
exposure source is not found for a number
of patients (6).
Although current epidemic curves and
spread rate at West Africa are consis-
tent with contact, person-to-person trans-
mission, rather than an epidemic pat-
tern similar to that of diseases that
have airborne/droplet transmission such as
influenza or SARS, an alternative mode of
transmission may be possible in particular
situations.
In healthcare facilities, our infection
control precautions need to be very
schematic according to our understand-
ing of suspected transmission mechanisms
such as, airborne, droplet, or contact (7),
but flexible enough to cope with condi-
tional emerging risks. Being so, precautions
are presented as one or the other (standard,
droplet, airborne, or contact precautions),
(1) airborne particles come in two sizes –
those 10µm in size or less that stay in
the air and those over 10µm in size that
fall after about 6 feet; either could occur
and be infectious in late stages of diseases.
The infections that occurred in health care
workers from Madrid and Dallas should be
analyzed not only in regard of faults in the
compliance with the precautions but also
in the directions given in extreme contact
precautions (8).
The Ebola-infected patient reaches at
some point a high viral load in all body
liquids and secretions due to several immu-
noevasion mechanisms resulting in unre-
stricted viral replication and dissemination
(9). (2) If we consider that the infectious
dose may be very low – at only 10 virus
particles (3) – and that an airborne parti-
cle may contain thousands of Ebola viri-
ons, thus an exposure carried by air can be
risky. Due to symptoms such as vomiting,
coughing, bleeding, and defecating, not
to mention defective respirator pumping
devices, or even syringe plunges, splashes,
and aerosols are easily created (10). If the
virus requires an extremely low inoculum
to cause infection and some viral parti-
cles can persist infective in the airborne
droplet nuclei, a measurable risk of air-
borne transmission would be present, even
keeping compliance with contact precau-
tions.
At the time, this note was submitted,
an ending of Ebola virus epidemic in West
Africa is still uncertain, even so, attending
the lessons of environmental epidemiology,
distinguishing communalities and differ-
ences in the context transmission take place
is on sake of identifying strategies to cut
off efficient and/or un-efficient means of
dispersion. Therefore, we should separate
two different settings. One is the African
transmission in which contact is the most
probable cause of the explosive contagion.
The other implies the transmission in spite
of the contact precautions in place because
of patients with high viral load generating
aerosols or droplets.
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Certainly, this hypothesis should be
tested, but for time being the repeated
transmission in the described setting war-
rants considering airborne/droplet trans-
mission at some moment of the disease.
The precaution emphasis may be widened
and negative pressure rooms may be imple-
mented for these patients.
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